Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can ear acupressure plus eye drops curb Kids' myopia?

NCT ID NCT07537166

Disease control Sponsor: China Medical University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether combining low-dose atropine eye drops (0.01% or 0.025%) with ear acupressure can safely slow myopia progression in 420 children aged 6-12. Participants are randomly assigned to one of six groups, including placebo, and are followed for 12 weeks. The goal is to find a safer alternative to standard higher-dose atropine, which can harm the cornea.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
low-dose atropine eye drops (0.01% and 0.025%) combined with auricular acupoint stimulation
What this could lead to
If successful, this could offer a safer, non-invasive way to slow myopia progression in children, reducing the need for stronger treatments.
What could go wrong
This is a small pilot study with only 12 weeks of follow-up, so results may not be conclusive. The combination therapy may not work better than atropine alone, and ear acupressure effects are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 420 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children aged 6-12 years * Myopia after cycloplegia (spherical equivalent \> -0.5 D) * Astigmatism and anisometropia \< -2.0 D * Intraocular pressure \< 21 mmHg Exclusion Criteria: * Infection * Ulceration * Eyelid disorders * Ear disorders * Amblyopia or strabismus * Use of other pharmacological or invasive treatments for myopia during the study period (spectacles allowed) * Hematologic or other systemic diseases * Non-compliance with study protocol for more than 7 days * History of atropine allergy * Previous or current use of contact lenses or orthokeratology lenses * Previous or current use of bifocal or progressive lenses

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acupressure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acupressure

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • China Medical University Hospital

    Taichung, North Strict, 404, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.